Divi`s Laboratories is in the process of entering into a long-term supply agreement with a customer and is planning for capacity addition at its manufacturing facility with an estimated investment between Rs 650 crore to Rs 700 crore, to be funded from internal accruals. The proposed facility is expected to be operational around January, 2027.Powered by Capital Market - Live News

Divis Laboratories has appointed Dr. S. Devendra Rao (DIN: 10481393) as Additional Director designated as �Whole-time Director (Manufacturing)`, for a term of 5 years commencing from 10 February 2024. Powered by Capital Market - Live News

Net profit of Divi`s Laboratories rose 16.99% to Rs 358.00 crore in the quarter ended December 2023 as against Rs 306.00 crore during the previous quarter ended December 2022. Sales rose 8.61% to Rs 1855.00 crore in the quarter ended December 2023 as against Rs 1708.00 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales1855.001708.00 9 OPM %26.3623.95 - PBDT584.00522.00 12 PBT489.00435.00 12 NP358.00306.00 17 Powered by Capital Market - Live News

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 10 February 2024.Powered by Capital Market - Live News

Net profit of Divi`s Laboratories declined 29.41% to Rs 348.00 crore in the quarter ended September 2023 as against Rs 493.00 crore during the previous quarter ended September 2022. Sales rose 2.91% to Rs 1909.00 crore in the quarter ended September 2023 as against Rs 1855.00 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales1909.001855.00 3 OPM %25.0933.48 - PBDT564.00701.00 -20 PBT469.00615.00 -24 NP348.00493.00 -29 Powered by Capital Market - Live News